Crossmark

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice

Crossref DOI link: https://doi.org/10.1186/s13020-024-00953-7

Published Online: 2024-06-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xue, Xiaoyong

Wang, Le

Wu, Ruiyu

Li, Yufei

Liu, Runping

Ma, Zhi

Jia, Kexin

Zhang, Yinhao

Li, Xiaojiaoyang https://orcid.org/0000-0002-8997-9651
Funding

Funding for this research was provided by:

National Key Research and Development Program on Modernization of Traditional Chinese Medicine (2022YFC3502100)
License Information

Text and Data Mining valid from 2024-06-06

Version of Record valid from 2024-06-06
More Information

Article History

Received: 19 March 2024

Accepted: 31 May 2024

First Online: 6 June 2024

Declarations

:

: All animal studies and procedures were approved by the Institutional Animal Care and Use Committee of Beijing University of Chinese Medicine (BUCM-4–2020121003-4190) and performed following “Guide for the Care and Use of Laboratory Animals” and the “Principles for the Utilization and Care of Vertebrate Animals” guidelines.

: Not applicable.

: The authors declare that there are no competing interests.

Document is current

Any future updates will be listed below